Life Sciences: Innovation

(asked on 11th December 2020) - View Source

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to promote the UK as a destination for life sciences innovation, in the context of the Medicines and Healthcare products Regulatory Agency (MHRA) becoming the first regulator to approve the mRNA vaccine for covid-19 on 2 December 2020.


Answered by
Nadhim Zahawi Portrait
Nadhim Zahawi
This question was answered on 21st December 2020

The flexibility and pragmatism of the MHRA has been instrumental to our COVID response, including enabling us to approve the COVID-19 vaccine before any other country. The MHRA will continue to pioneer innovative regulatory approaches to the most ground-breaking treatments, from the latest AI-enabled technologies to the best new precision therapies, benefiting both patients and the sector.

Reticulating Splines